Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Merkel cell polyomavirus and human papilloma virus in proliferative skin lesions arising in patients treated with BRAF inhibitors.

Archives of dermatological research - 1 Jul 2016

Falchook G S, Rady P, Konopinski J C, Busaidy N, Hess K, Hymes S, Nguyen H P, Prieto V G, Bustinza-Linares E, Lin Q, Parkhurst K L, Hong D S, Sherman S, Tyring S K, Kurzrock R

Abstract excerpt

The potential role of oncogenic viruses mediating development of proliferative skin lesions in patients treated with RAF inhibitors is poorly understood. The objective of this study was to investigate human papilloma virus (HPV) and Merkel cell polyomavirus (MCPyV) in skin lesions among patients treated with RAF inhibitors with the help of a case series describing prevalence of HPV, MCPyV, and RAS mutations in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy
Share to Carcinoma, Squamous Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Imidazoles

Share to Oximes

Share to Papillomaviridae

Share to Skin Neoplasms

Source

Identifiers

PMID: 27098388
DOI: 10.1007/s00403-016-1650-y

Genes

BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Merkel cell polyomavirus and human papilloma virus in proliferative skin lesions arising in patients treated with BRAF inhibitors.PMID 27098388Read ↗

Presence of human polyomavirus 6 in mutation-specific BRAF inhibitor-induced epithelial proliferations.Semantic proximity Read ↗

Merkel Cell Polyoma Virus and Cutaneous Human Papillomavirus Types in Skin Cancers: Optimal Detection Assays, Pathogenic Mechanisms, and Therapeutic VaccinationSemantic proximity Read ↗

Merkel Cell Polyomavirus Infection and DetectionSemantic proximity Read ↗

Detection of Merkel Cell Polyomavirus DNA in Atypical Fibroxanthoma in Correlation to Clinical FeaturesSemantic proximity Read ↗

Clinical Factors Associated With Merkel Cell Polyomavirus Infection in Merkel Cell CarcinomaSemantic proximity Read ↗

Merkel Cell Polyomavirus DNA in Persons without Merkel Cell CarcinomaSemantic proximity Read ↗

Increased Detection of Merkel Cell Polyomavirus in Non-Melanoma Skin Cancer and Its Association with Host Immunogenetic ProfileSemantic proximity Read ↗

RAS mutations are associated with the development of cutaneous squamous cell tumors in patients treated with RAF inhibitors.Semantic proximity Read ↗

Frequent detection of human polyomavirus 6 in keratoacanthomasSemantic proximity Read ↗

Skin tumors induced by sorafenib; paradoxic RAS-RAF pathway activation and oncogenic mutations of HRAS, TP53, and TGFBR1.Semantic proximity Read ↗

Vemurafenib cooperates with HPV to promote initiation of cutaneous tumors.Semantic proximity Read ↗

Human papillomavirus-negative epithelial proliferations resembling condylomata acuminata in a patient receiving vemurafenib for Stage IV melanoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.